IDEC-C2B8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin’s lymphoma. - Maloney,D.G.; Grillo-Lopez,A.J.; Bodkin,D.J.; White,C.A.; Liles,T-M.; Rayston,I.; Varns,C.; Rosenberg,J.; Levy,R. (J Clin Oncol, 1997)